nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—Dacarbazine—sarcoma	0.118	0.208	CbGbCtD
Fluphenazine—CYP2E1—Mitoxantrone—sarcoma	0.0913	0.162	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—sarcoma	0.0681	0.12	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—sarcoma	0.0576	0.102	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—sarcoma	0.0516	0.0913	CbGbCtD
Fluphenazine—ABCB1—Mitoxantrone—sarcoma	0.0462	0.0817	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—sarcoma	0.0333	0.0589	CbGbCtD
Fluphenazine—ABCB1—Vincristine—sarcoma	0.0318	0.0562	CbGbCtD
Fluphenazine—ABCB1—Etoposide—sarcoma	0.0291	0.0515	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—sarcoma	0.0199	0.0351	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—sarcoma	0.0187	0.0331	CbGbCtD
Fluphenazine—Pigmentation disorder—Thiotepa—sarcoma	0.00535	0.0405	CcSEcCtD
Fluphenazine—HTR2A—pulmonary artery—sarcoma	0.00423	0.0543	CbGeAlD
Fluphenazine—Pigmentation disorder—Etoposide—sarcoma	0.00384	0.0291	CcSEcCtD
Fluphenazine—Ileus paralytic—Vincristine—sarcoma	0.00366	0.0277	CcSEcCtD
Fluphenazine—Throat tightness—Etoposide—sarcoma	0.00262	0.0198	CcSEcCtD
Fluphenazine—HTR2A—hindlimb—sarcoma	0.00256	0.0329	CbGeAlD
Fluphenazine—Faecalith—Epirubicin—sarcoma	0.00252	0.019	CcSEcCtD
Fluphenazine—Faecaloma—Epirubicin—sarcoma	0.00252	0.019	CcSEcCtD
Fluphenazine—Extrapyramidal disorder—Thiotepa—sarcoma	0.00237	0.0179	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—sarcoma	0.00233	0.0176	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—sarcoma	0.00233	0.0176	CcSEcCtD
Fluphenazine—CALM3—mammary gland—sarcoma	0.00224	0.0288	CbGeAlD
Fluphenazine—HTR2A—appendage—sarcoma	0.0022	0.0282	CbGeAlD
Fluphenazine—CALM2—endothelium—sarcoma	0.00219	0.0281	CbGeAlD
Fluphenazine—CALM1—endothelium—sarcoma	0.00218	0.0279	CbGeAlD
Fluphenazine—Pigmentation disorder—Epirubicin—sarcoma	0.00215	0.0163	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—sarcoma	0.00199	0.0151	CcSEcCtD
Fluphenazine—CALM1—mammary gland—sarcoma	0.00175	0.0225	CbGeAlD
Fluphenazine—CALM3—myometrium—sarcoma	0.00159	0.0204	CbGeAlD
Fluphenazine—CALM3—seminal vesicle—sarcoma	0.00144	0.0185	CbGeAlD
Fluphenazine—Urine output increased—Vincristine—sarcoma	0.00143	0.0108	CcSEcCtD
Fluphenazine—HTR2A—endothelium—sarcoma	0.00133	0.017	CbGeAlD
Fluphenazine—Lethargy—Dactinomycin—sarcoma	0.00131	0.00993	CcSEcCtD
Fluphenazine—Polyuria—Vincristine—sarcoma	0.00131	0.0099	CcSEcCtD
Fluphenazine—CALM2—myometrium—sarcoma	0.00125	0.016	CbGeAlD
Fluphenazine—CALM1—myometrium—sarcoma	0.00124	0.016	CbGeAlD
Fluphenazine—Cardiac arrest—Thiotepa—sarcoma	0.00123	0.00932	CcSEcCtD
Fluphenazine—Renal failure acute—Mitoxantrone—sarcoma	0.00121	0.00917	CcSEcCtD
Fluphenazine—CALM3—smooth muscle tissue—sarcoma	0.0012	0.0155	CbGeAlD
Fluphenazine—CALM2—embryo—sarcoma	0.0012	0.0154	CbGeAlD
Fluphenazine—CALM1—embryo—sarcoma	0.0012	0.0154	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00116	0.00875	CcSEcCtD
Fluphenazine—CALM2—seminal vesicle—sarcoma	0.00113	0.0145	CbGeAlD
Fluphenazine—Dysphagia—Dactinomycin—sarcoma	0.00111	0.00841	CcSEcCtD
Fluphenazine—Cardiac arrest—Vincristine—sarcoma	0.00109	0.00827	CcSEcCtD
Fluphenazine—HTR1A—hematopoietic system—sarcoma	0.00109	0.014	CbGeAlD
Fluphenazine—CALM2—hematopoietic system—sarcoma	0.00107	0.0138	CbGeAlD
Fluphenazine—CALM1—hematopoietic system—sarcoma	0.00107	0.0137	CbGeAlD
Fluphenazine—Pancytopenia—Thiotepa—sarcoma	0.00106	0.00805	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—sarcoma	0.00106	0.00799	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—sarcoma	0.00105	0.00798	CcSEcCtD
Fluphenazine—CALM3—cardiac atrium—sarcoma	0.00104	0.0133	CbGeAlD
Fluphenazine—CALM2—connective tissue—sarcoma	0.00103	0.0133	CbGeAlD
Fluphenazine—CALM3—uterus—sarcoma	0.00103	0.0133	CbGeAlD
Fluphenazine—CALM1—connective tissue—sarcoma	0.00103	0.0132	CbGeAlD
Fluphenazine—Pneumonia—Thiotepa—sarcoma	0.001	0.0076	CcSEcCtD
Fluphenazine—Pneumonia—Dactinomycin—sarcoma	0.000997	0.00754	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—sarcoma	0.000976	0.00738	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—sarcoma	0.000971	0.00735	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Etoposide—sarcoma	0.000962	0.00728	CcSEcCtD
Fluphenazine—CALM2—smooth muscle tissue—sarcoma	0.000945	0.0121	CbGeAlD
Fluphenazine—Pancytopenia—Vincristine—sarcoma	0.000943	0.00714	CcSEcCtD
Fluphenazine—CALM1—smooth muscle tissue—sarcoma	0.000941	0.0121	CbGeAlD
Fluphenazine—CALM2—skin of body—sarcoma	0.000933	0.012	CbGeAlD
Fluphenazine—Agranulocytosis—Thiotepa—sarcoma	0.000932	0.00705	CcSEcCtD
Fluphenazine—CALM1—skin of body—sarcoma	0.000929	0.0119	CbGeAlD
Fluphenazine—Agranulocytosis—Dactinomycin—sarcoma	0.000925	0.007	CcSEcCtD
Fluphenazine—Pancytopenia—Mitoxantrone—sarcoma	0.000919	0.00695	CcSEcCtD
Fluphenazine—HRH1—myometrium—sarcoma	0.000908	0.0116	CbGeAlD
Fluphenazine—Photosensitivity reaction—Vincristine—sarcoma	0.000907	0.00686	CcSEcCtD
Fluphenazine—CALM3—tendon—sarcoma	0.000905	0.0116	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.000899	0.0068	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—sarcoma	0.000899	0.0068	CcSEcCtD
Fluphenazine—ADRA2A—myometrium—sarcoma	0.000891	0.0114	CbGeAlD
Fluphenazine—Pneumonia—Vincristine—sarcoma	0.000891	0.00674	CcSEcCtD
Fluphenazine—Cardiac arrest—Etoposide—sarcoma	0.000885	0.0067	CcSEcCtD
Fluphenazine—CALM3—bone marrow—sarcoma	0.000876	0.0112	CbGeAlD
Fluphenazine—Pneumonia—Mitoxantrone—sarcoma	0.000868	0.00656	CcSEcCtD
Fluphenazine—Drowsiness—Mitoxantrone—sarcoma	0.000863	0.00652	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—sarcoma	0.000861	0.00651	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—sarcoma	0.000855	0.00646	CcSEcCtD
Fluphenazine—CYP1A2—hematopoietic system—sarcoma	0.000832	0.0107	CbGeAlD
Fluphenazine—Jaundice cholestatic—Epirubicin—sarcoma	0.000818	0.00619	CcSEcCtD
Fluphenazine—CALM2—cardiac atrium—sarcoma	0.000815	0.0105	CbGeAlD
Fluphenazine—CALM1—cardiac atrium—sarcoma	0.000811	0.0104	CbGeAlD
Fluphenazine—CALM2—uterus—sarcoma	0.000811	0.0104	CbGeAlD
Fluphenazine—CALM1—uterus—sarcoma	0.000807	0.0104	CbGeAlD
Fluphenazine—ADRA2A—seminal vesicle—sarcoma	0.000805	0.0103	CbGeAlD
Fluphenazine—Agranulocytosis—Mitoxantrone—sarcoma	0.000805	0.00609	CcSEcCtD
Fluphenazine—Dysphagia—Etoposide—sarcoma	0.000805	0.00609	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—sarcoma	0.000797	0.00602	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—sarcoma	0.000791	0.00598	CcSEcCtD
Fluphenazine—CYP2E1—seminal vesicle—sarcoma	0.000788	0.0101	CbGeAlD
Fluphenazine—Erythema—Thiotepa—sarcoma	0.000781	0.0059	CcSEcCtD
Fluphenazine—HRH1—hematopoietic system—sarcoma	0.000779	0.01	CbGeAlD
Fluphenazine—Erythema—Dactinomycin—sarcoma	0.000775	0.00586	CcSEcCtD
Fluphenazine—ADRA2A—hematopoietic system—sarcoma	0.000765	0.00982	CbGeAlD
Fluphenazine—Dyskinesia—Epirubicin—sarcoma	0.000765	0.00579	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—sarcoma	0.000764	0.00578	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—sarcoma	0.000757	0.00573	CcSEcCtD
Fluphenazine—CALM2—lymphoid tissue—sarcoma	0.000756	0.0097	CbGeAlD
Fluphenazine—CALM1—lymphoid tissue—sarcoma	0.000752	0.00965	CbGeAlD
Fluphenazine—HRH1—connective tissue—sarcoma	0.00075	0.00963	CbGeAlD
Fluphenazine—CALM3—testis—sarcoma	0.000749	0.00961	CbGeAlD
Fluphenazine—CYP2E1—hematopoietic system—sarcoma	0.000749	0.00961	CbGeAlD
Fluphenazine—ADRA2A—connective tissue—sarcoma	0.000737	0.00946	CbGeAlD
Fluphenazine—Vision blurred—Thiotepa—sarcoma	0.000736	0.00556	CcSEcCtD
Fluphenazine—HTR2A—embryo—sarcoma	0.000729	0.00936	CbGeAlD
Fluphenazine—Pneumonia—Etoposide—sarcoma	0.000722	0.00546	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—sarcoma	0.000719	0.00544	CcSEcCtD
Fluphenazine—Agitation—Thiotepa—sarcoma	0.000717	0.00543	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—sarcoma	0.000711	0.00537	CcSEcCtD
Fluphenazine—CALM2—tendon—sarcoma	0.00071	0.00912	CbGeAlD
Fluphenazine—CALM3—liver—sarcoma	0.000708	0.00909	CbGeAlD
Fluphenazine—Dyskinesia—Doxorubicin—sarcoma	0.000708	0.00535	CcSEcCtD
Fluphenazine—CALM1—tendon—sarcoma	0.000707	0.00908	CbGeAlD
Fluphenazine—Leukopenia—Thiotepa—sarcoma	0.000699	0.00528	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—sarcoma	0.000698	0.00528	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—sarcoma	0.000694	0.00524	CcSEcCtD
Fluphenazine—CALM2—bone marrow—sarcoma	0.000688	0.00883	CbGeAlD
Fluphenazine—HRH1—smooth muscle tissue—sarcoma	0.000686	0.00881	CbGeAlD
Fluphenazine—CALM1—bone marrow—sarcoma	0.000685	0.00879	CbGeAlD
Fluphenazine—Erythema—Mitoxantrone—sarcoma	0.000674	0.0051	CcSEcCtD
Fluphenazine—Hypertension—Thiotepa—sarcoma	0.000674	0.0051	CcSEcCtD
Fluphenazine—Agranulocytosis—Etoposide—sarcoma	0.00067	0.00506	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—sarcoma	0.000665	0.00503	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—sarcoma	0.000658	0.00497	CcSEcCtD
Fluphenazine—HTR2A—hematopoietic system—sarcoma	0.000651	0.00835	CbGeAlD
Fluphenazine—Salivary hypersecretion—Doxorubicin—sarcoma	0.000646	0.00489	CcSEcCtD
Fluphenazine—Agitation—Vincristine—sarcoma	0.000636	0.00481	CcSEcCtD
Fluphenazine—Vision blurred—Mitoxantrone—sarcoma	0.000635	0.0048	CcSEcCtD
Fluphenazine—HTR2A—connective tissue—sarcoma	0.000627	0.00804	CbGeAlD
Fluphenazine—Tachycardia—Thiotepa—sarcoma	0.000622	0.0047	CcSEcCtD
Fluphenazine—Leukopenia—Vincristine—sarcoma	0.00062	0.00469	CcSEcCtD
Fluphenazine—Skin disorder—Thiotepa—sarcoma	0.000619	0.00468	CcSEcCtD
Fluphenazine—Leukopenia—Mitoxantrone—sarcoma	0.000603	0.00456	CcSEcCtD
Fluphenazine—Hypertension—Vincristine—sarcoma	0.000598	0.00452	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—sarcoma	0.000594	0.0045	CcSEcCtD
Fluphenazine—CYP2D6—hematopoietic system—sarcoma	0.000593	0.00761	CbGeAlD
Fluphenazine—CALM2—testis—sarcoma	0.000588	0.00755	CbGeAlD
Fluphenazine—CALM1—testis—sarcoma	0.000585	0.00751	CbGeAlD
Fluphenazine—Hypertension—Mitoxantrone—sarcoma	0.000582	0.0044	CcSEcCtD
Fluphenazine—ADRA2A—cardiac atrium—sarcoma	0.000581	0.00746	CbGeAlD
Fluphenazine—Eczema—Epirubicin—sarcoma	0.000581	0.00439	CcSEcCtD
Fluphenazine—ADRA2A—uterus—sarcoma	0.000578	0.00742	CbGeAlD
Fluphenazine—HTR2A—smooth muscle tissue—sarcoma	0.000573	0.00736	CbGeAlD
Fluphenazine—Somnolence—Thiotepa—sarcoma	0.000566	0.00428	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—sarcoma	0.000565	0.00428	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—sarcoma	0.000565	0.00427	CcSEcCtD
Fluphenazine—CALM2—liver—sarcoma	0.000556	0.00714	CbGeAlD
Fluphenazine—Decreased appetite—Thiotepa—sarcoma	0.000554	0.00419	CcSEcCtD
Fluphenazine—CALM1—liver—sarcoma	0.000554	0.0071	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Epirubicin—sarcoma	0.000553	0.00418	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00055	0.00416	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—sarcoma	0.00055	0.00416	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—sarcoma	0.00055	0.00416	CcSEcCtD
Fluphenazine—Constipation—Thiotepa—sarcoma	0.000545	0.00412	CcSEcCtD
Fluphenazine—CALM3—lymph node—sarcoma	0.000543	0.00697	CbGeAlD
Fluphenazine—DRD2—testis—sarcoma	0.000541	0.00694	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000539	0.00408	CcSEcCtD
Fluphenazine—Muscle spasms—Etoposide—sarcoma	0.000539	0.00408	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—sarcoma	0.000537	0.00406	CcSEcCtD
Fluphenazine—Tachycardia—Mitoxantrone—sarcoma	0.000537	0.00406	CcSEcCtD
Fluphenazine—Skin disorder—Mitoxantrone—sarcoma	0.000534	0.00404	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—sarcoma	0.000533	0.00403	CcSEcCtD
Fluphenazine—Hypotension—Vincristine—sarcoma	0.000528	0.00399	CcSEcCtD
Fluphenazine—CYP2E1—lymphoid tissue—sarcoma	0.000527	0.00677	CbGeAlD
Fluphenazine—Renal failure acute—Doxorubicin—sarcoma	0.000523	0.00396	CcSEcCtD
Fluphenazine—HRH1—tendon—sarcoma	0.000516	0.00662	CbGeAlD
Fluphenazine—Hypotension—Mitoxantrone—sarcoma	0.000514	0.00389	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000512	0.00387	CcSEcCtD
Fluphenazine—ADRA2A—tendon—sarcoma	0.000507	0.0065	CbGeAlD
Fluphenazine—Urticaria—Thiotepa—sarcoma	0.000506	0.00383	CcSEcCtD
Fluphenazine—Body temperature increased—Thiotepa—sarcoma	0.000504	0.00381	CcSEcCtD
Fluphenazine—Leukopenia—Etoposide—sarcoma	0.000502	0.0038	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—sarcoma	0.0005	0.00378	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000499	0.00377	CcSEcCtD
Fluphenazine—ABCB1—myometrium—sarcoma	0.000497	0.00638	CbGeAlD
Fluphenazine—Cardiac arrest—Epirubicin—sarcoma	0.000496	0.00375	CcSEcCtD
Fluphenazine—CYP2E1—tendon—sarcoma	0.000496	0.00636	CbGeAlD
Fluphenazine—Lethargy—Doxorubicin—sarcoma	0.000493	0.00373	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—sarcoma	0.000491	0.00371	CcSEcCtD
Fluphenazine—Dyspnoea—Mitoxantrone—sarcoma	0.000491	0.00371	CcSEcCtD
Fluphenazine—Somnolence—Mitoxantrone—sarcoma	0.000489	0.0037	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—sarcoma	0.000484	0.00366	CcSEcCtD
Fluphenazine—Constipation—Vincristine—sarcoma	0.000483	0.00365	CcSEcCtD
Fluphenazine—Decreased appetite—Mitoxantrone—sarcoma	0.000478	0.00362	CcSEcCtD
Fluphenazine—ABCB1—embryo—sarcoma	0.000478	0.00613	CbGeAlD
Fluphenazine—Constipation—Mitoxantrone—sarcoma	0.00047	0.00356	CcSEcCtD
Fluphenazine—Hypersensitivity—Thiotepa—sarcoma	0.000469	0.00355	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—sarcoma	0.000466	0.00352	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—sarcoma	0.000459	0.00347	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—sarcoma	0.000458	0.00346	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—sarcoma	0.000451	0.00341	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—sarcoma	0.000451	0.00341	CcSEcCtD
Fluphenazine—Pruritus—Thiotepa—sarcoma	0.000451	0.00341	CcSEcCtD
Fluphenazine—ABCB1—seminal vesicle—sarcoma	0.000449	0.00576	CbGeAlD
Fluphenazine—Tachycardia—Etoposide—sarcoma	0.000447	0.00338	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—sarcoma	0.000447	0.00338	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—sarcoma	0.000447	0.00338	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—sarcoma	0.000445	0.00336	CcSEcCtD
Fluphenazine—Urticaria—Mitoxantrone—sarcoma	0.000437	0.00331	CcSEcCtD
Fluphenazine—Body temperature increased—Mitoxantrone—sarcoma	0.000435	0.00329	CcSEcCtD
Fluphenazine—CYP1A2—liver—sarcoma	0.000431	0.00554	CbGeAlD
Fluphenazine—HTR2A—tendon—sarcoma	0.000431	0.00553	CbGeAlD
Fluphenazine—Pancytopenia—Epirubicin—sarcoma	0.000428	0.00324	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—sarcoma	0.000428	0.00323	CcSEcCtD
Fluphenazine—HRH1—testis—sarcoma	0.000427	0.00548	CbGeAlD
Fluphenazine—ABCB1—hematopoietic system—sarcoma	0.000426	0.00547	CbGeAlD
Fluphenazine—CALM2—lymph node—sarcoma	0.000426	0.00547	CbGeAlD
Fluphenazine—CALM1—lymph node—sarcoma	0.000424	0.00545	CbGeAlD
Fluphenazine—ADRA2A—testis—sarcoma	0.000419	0.00538	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000419	0.00317	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—sarcoma	0.000417	0.00316	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—sarcoma	0.000417	0.00316	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—sarcoma	0.000416	0.00315	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—sarcoma	0.000413	0.00313	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—sarcoma	0.000412	0.00311	CcSEcCtD
Fluphenazine—CYP2E1—testis—sarcoma	0.00041	0.00527	CbGeAlD
Fluphenazine—Dyspnoea—Etoposide—sarcoma	0.000408	0.00309	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—sarcoma	0.000407	0.00308	CcSEcCtD
Fluphenazine—Hypersensitivity—Mitoxantrone—sarcoma	0.000405	0.00307	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—sarcoma	0.000405	0.00306	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—sarcoma	0.000402	0.00304	CcSEcCtD
Fluphenazine—Headache—Thiotepa—sarcoma	0.000399	0.00302	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—sarcoma	0.000398	0.00301	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—sarcoma	0.000396	0.003	CcSEcCtD
Fluphenazine—Constipation—Etoposide—sarcoma	0.000391	0.00296	CcSEcCtD
Fluphenazine—CYP2E1—liver—sarcoma	0.000388	0.00498	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000388	0.00293	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000381	0.00288	CcSEcCtD
Fluphenazine—Nausea—Thiotepa—sarcoma	0.000378	0.00286	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—sarcoma	0.000376	0.00284	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—sarcoma	0.000375	0.00284	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—sarcoma	0.000374	0.00283	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—sarcoma	0.000372	0.00281	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—sarcoma	0.000364	0.00275	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—sarcoma	0.000362	0.00274	CcSEcCtD
Fluphenazine—HTR2A—testis—sarcoma	0.000357	0.00458	CbGeAlD
Fluphenazine—Oedema peripheral—Epirubicin—sarcoma	0.000356	0.00269	CcSEcCtD
Fluphenazine—Headache—Vincristine—sarcoma	0.000354	0.00268	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—sarcoma	0.000347	0.00263	CcSEcCtD
Fluphenazine—Headache—Mitoxantrone—sarcoma	0.000345	0.00261	CcSEcCtD
Fluphenazine—HTR2A—liver—sarcoma	0.000337	0.00433	CbGeAlD
Fluphenazine—Hypersensitivity—Etoposide—sarcoma	0.000337	0.00255	CcSEcCtD
Fluphenazine—Nausea—Vincristine—sarcoma	0.000336	0.00254	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—sarcoma	0.000329	0.00249	CcSEcCtD
Fluphenazine—Nausea—Mitoxantrone—sarcoma	0.000327	0.00247	CcSEcCtD
Fluphenazine—CYP2D6—testis—sarcoma	0.000325	0.00417	CbGeAlD
Fluphenazine—Pruritus—Etoposide—sarcoma	0.000324	0.00245	CcSEcCtD
Fluphenazine—ABCB1—uterus—sarcoma	0.000322	0.00413	CbGeAlD
Fluphenazine—Erythema—Epirubicin—sarcoma	0.000314	0.00238	CcSEcCtD
Fluphenazine—HRH1—lymph node—sarcoma	0.00031	0.00397	CbGeAlD
Fluphenazine—CYP2D6—liver—sarcoma	0.000307	0.00394	CbGeAlD
Fluphenazine—ADRA2A—lymph node—sarcoma	0.000304	0.0039	CbGeAlD
Fluphenazine—Muscle spasms—Epirubicin—sarcoma	0.000302	0.00229	CcSEcCtD
Fluphenazine—ABCB1—lymphoid tissue—sarcoma	0.0003	0.00385	CbGeAlD
Fluphenazine—Vision blurred—Epirubicin—sarcoma	0.000296	0.00224	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—sarcoma	0.000291	0.0022	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—sarcoma	0.000289	0.00218	CcSEcCtD
Fluphenazine—Headache—Etoposide—sarcoma	0.000287	0.00217	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—sarcoma	0.000281	0.00213	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—sarcoma	0.00028	0.00211	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—sarcoma	0.000274	0.00207	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—sarcoma	0.000273	0.00351	CbGeAlD
Fluphenazine—Nausea—Etoposide—sarcoma	0.000272	0.00206	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—sarcoma	0.000271	0.00205	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—sarcoma	0.000267	0.00202	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—sarcoma	0.000262	0.00198	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—sarcoma	0.00026	0.00197	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—sarcoma	0.000257	0.00194	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—sarcoma	0.000251	0.0019	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—sarcoma	0.00025	0.00189	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—sarcoma	0.000249	0.00188	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—sarcoma	0.000242	0.00183	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—sarcoma	0.00024	0.00181	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—sarcoma	0.000237	0.0018	CcSEcCtD
Fluphenazine—ABCB1—testis—sarcoma	0.000234	0.003	CbGeAlD
Fluphenazine—Tachycardia—Doxorubicin—sarcoma	0.000232	0.00175	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—sarcoma	0.000231	0.00174	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—sarcoma	0.000229	0.00173	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—sarcoma	0.000228	0.00172	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—sarcoma	0.000223	0.00169	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—sarcoma	0.000222	0.00168	CcSEcCtD
Fluphenazine—ABCB1—liver—sarcoma	0.000221	0.00284	CbGeAlD
Fluphenazine—Constipation—Epirubicin—sarcoma	0.000219	0.00166	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—sarcoma	0.000212	0.0016	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—sarcoma	0.000211	0.0016	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—sarcoma	0.000206	0.00156	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—sarcoma	0.000204	0.00154	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—sarcoma	0.000203	0.00154	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—sarcoma	0.000203	0.00153	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—sarcoma	0.000189	0.00143	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—sarcoma	0.000189	0.00143	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—sarcoma	0.000188	0.00142	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—sarcoma	0.000181	0.00137	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—sarcoma	0.000175	0.00132	CcSEcCtD
Fluphenazine—ABCB1—lymph node—sarcoma	0.000169	0.00217	CbGeAlD
Fluphenazine—Pruritus—Doxorubicin—sarcoma	0.000168	0.00127	CcSEcCtD
Fluphenazine—Headache—Epirubicin—sarcoma	0.000161	0.00122	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—sarcoma	0.000152	0.00115	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—sarcoma	0.000149	0.00112	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—sarcoma	0.000141	0.00107	CcSEcCtD
Fluphenazine—DRD1—Signaling by GPCR—HRAS—sarcoma	1.91e-05	8.52e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MDM2—sarcoma	1.9e-05	8.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MDM2—sarcoma	1.9e-05	8.46e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—HRAS—sarcoma	1.89e-05	8.4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CREB1—sarcoma	1.88e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—SRC—sarcoma	1.87e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL2—sarcoma	1.86e-05	8.27e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL2—sarcoma	1.86e-05	8.27e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—HRAS—sarcoma	1.85e-05	8.24e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CREB1—sarcoma	1.85e-05	8.23e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CREB1—sarcoma	1.85e-05	8.21e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL2—sarcoma	1.84e-05	8.19e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—VEGFA—sarcoma	1.82e-05	8.09e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL2—sarcoma	1.82e-05	8.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MDM2—sarcoma	1.81e-05	8.07e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.8e-05	8.01e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NRAS—sarcoma	1.79e-05	7.99e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCND1—sarcoma	1.79e-05	7.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—HRAS—sarcoma	1.79e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—HRAS—sarcoma	1.79e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—JUN—sarcoma	1.79e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—HRAS—sarcoma	1.78e-05	7.91e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CTNNB1—sarcoma	1.78e-05	7.91e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MDM2—sarcoma	1.77e-05	7.88e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCND1—sarcoma	1.77e-05	7.88e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.77e-05	7.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KIT—sarcoma	1.77e-05	7.87e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	1.77e-05	7.87e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—JUN—sarcoma	1.77e-05	7.86e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—EGFR—sarcoma	1.77e-05	7.86e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MDM2—sarcoma	1.76e-05	7.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL2—sarcoma	1.76e-05	7.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MDM2—sarcoma	1.75e-05	7.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MDM2—sarcoma	1.75e-05	7.81e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CTNNB1—sarcoma	1.75e-05	7.8e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KDR—sarcoma	1.75e-05	7.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—HRAS—sarcoma	1.72e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—HRAS—sarcoma	1.72e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—JUN—sarcoma	1.71e-05	7.6e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—KRAS—sarcoma	1.7e-05	7.56e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL2—sarcoma	1.7e-05	7.56e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL2—sarcoma	1.7e-05	7.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CTNNB1—sarcoma	1.69e-05	7.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KDR—sarcoma	1.69e-05	7.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KDR—sarcoma	1.69e-05	7.54e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CREB1—sarcoma	1.68e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.67e-05	7.44e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MYC—sarcoma	1.67e-05	7.44e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—KRAS—sarcoma	1.67e-05	7.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—JUN—sarcoma	1.65e-05	7.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—JUN—sarcoma	1.65e-05	7.35e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—HRAS—sarcoma	1.65e-05	7.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CTNNB1—sarcoma	1.64e-05	7.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CTNNB1—sarcoma	1.64e-05	7.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—HRAS—sarcoma	1.64e-05	7.29e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—EGFR—sarcoma	1.63e-05	7.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KIT—sarcoma	1.61e-05	7.18e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—NRAS—sarcoma	1.61e-05	7.18e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	1.61e-05	7.17e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—SRC—sarcoma	1.61e-05	7.15e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—SRC—sarcoma	1.58e-05	7.05e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL2—sarcoma	1.58e-05	7.04e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL2—sarcoma	1.57e-05	7.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CTNNB1—sarcoma	1.56e-05	6.96e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—sarcoma	1.56e-05	6.96e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KIT—sarcoma	1.56e-05	6.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KIT—sarcoma	1.56e-05	6.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—NRAS—sarcoma	1.56e-05	6.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—NRAS—sarcoma	1.56e-05	6.94e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MDM2—sarcoma	1.55e-05	6.92e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NRAS—sarcoma	1.54e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KRAS—sarcoma	1.54e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—sarcoma	1.54e-05	6.87e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCND1—sarcoma	1.54e-05	6.87e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—JUN—sarcoma	1.54e-05	6.85e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CREB1—sarcoma	1.53e-05	6.83e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCND1—sarcoma	1.53e-05	6.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—SRC—sarcoma	1.53e-05	6.82e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—JUN—sarcoma	1.53e-05	6.82e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MDM2—sarcoma	1.53e-05	6.81e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	1.53e-05	6.8e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MDM2—sarcoma	1.53e-05	6.8e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NRAS—sarcoma	1.52e-05	6.78e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	1.52e-05	6.77e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	1.52e-05	6.77e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CTNNB1—sarcoma	1.51e-05	6.74e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CTNNB1—sarcoma	1.51e-05	6.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CREB1—sarcoma	1.48e-05	6.61e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CREB1—sarcoma	1.48e-05	6.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—SRC—sarcoma	1.48e-05	6.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—SRC—sarcoma	1.48e-05	6.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NRAS—sarcoma	1.47e-05	6.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EGFR—sarcoma	1.47e-05	6.54e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.44e-05	6.43e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MYC—sarcoma	1.44e-05	6.41e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NRAS—sarcoma	1.43e-05	6.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NRAS—sarcoma	1.43e-05	6.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EGFR—sarcoma	1.42e-05	6.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EGFR—sarcoma	1.42e-05	6.33e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—HRAS—sarcoma	1.42e-05	6.33e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MYC—sarcoma	1.42e-05	6.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—HRAS—sarcoma	1.42e-05	6.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—SRC—sarcoma	1.41e-05	6.29e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EGFR—sarcoma	1.41e-05	6.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MDM2—sarcoma	1.39e-05	6.2e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL2—sarcoma	1.39e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EGFR—sarcoma	1.39e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—sarcoma	1.39e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SRC—sarcoma	1.38e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SRC—sarcoma	1.37e-05	6.11e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—sarcoma	1.37e-05	6.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—SRC—sarcoma	1.37e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—SRC—sarcoma	1.37e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL2—sarcoma	1.37e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL2—sarcoma	1.36e-05	6.07e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—sarcoma	1.36e-05	6.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCND1—sarcoma	1.35e-05	6.03e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—JUN—sarcoma	1.35e-05	6.02e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—sarcoma	1.34e-05	5.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—sarcoma	1.34e-05	5.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—sarcoma	1.34e-05	5.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—sarcoma	1.34e-05	5.98e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.34e-05	5.97e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—sarcoma	1.34e-05	5.96e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—sarcoma	1.33e-05	5.93e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—JUN—sarcoma	1.33e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—sarcoma	1.33e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—sarcoma	1.33e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—sarcoma	1.33e-05	5.91e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—JUN—sarcoma	1.33e-05	5.91e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—sarcoma	1.32e-05	5.88e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	1.32e-05	5.87e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—sarcoma	1.32e-05	5.86e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—sarcoma	1.32e-05	5.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—sarcoma	1.32e-05	5.86e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—sarcoma	1.31e-05	5.84e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—sarcoma	1.31e-05	5.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—sarcoma	1.3e-05	5.78e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—sarcoma	1.3e-05	5.78e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	1.29e-05	5.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MDM2—sarcoma	1.27e-05	5.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—sarcoma	1.27e-05	5.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—sarcoma	1.27e-05	5.64e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—sarcoma	1.24e-05	5.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—sarcoma	1.24e-05	5.52e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—sarcoma	1.24e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—sarcoma	1.23e-05	5.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—sarcoma	1.23e-05	5.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—sarcoma	1.23e-05	5.47e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—sarcoma	1.23e-05	5.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—sarcoma	1.23e-05	5.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—sarcoma	1.23e-05	5.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—sarcoma	1.23e-05	5.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—sarcoma	1.21e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—sarcoma	1.21e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—sarcoma	1.21e-05	5.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—sarcoma	1.21e-05	5.39e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—sarcoma	1.2e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	1.2e-05	5.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—sarcoma	1.2e-05	5.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—sarcoma	1.2e-05	5.34e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—sarcoma	1.19e-05	5.31e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—sarcoma	1.19e-05	5.3e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—sarcoma	1.18e-05	5.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—sarcoma	1.18e-05	5.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—sarcoma	1.18e-05	5.25e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—sarcoma	1.17e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—sarcoma	1.17e-05	5.19e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—sarcoma	1.17e-05	5.19e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—sarcoma	1.16e-05	5.17e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—sarcoma	1.16e-05	5.16e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—sarcoma	1.15e-05	5.11e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—sarcoma	1.15e-05	5.1e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—sarcoma	1.14e-05	5.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—sarcoma	1.14e-05	5.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—sarcoma	1.14e-05	5.08e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—sarcoma	1.14e-05	5.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—sarcoma	1.13e-05	5.05e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—sarcoma	1.13e-05	5.04e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—sarcoma	1.13e-05	5.04e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—sarcoma	1.13e-05	5.03e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—sarcoma	1.12e-05	4.96e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—sarcoma	1.11e-05	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—sarcoma	1.1e-05	4.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—sarcoma	1.1e-05	4.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—sarcoma	1.1e-05	4.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—sarcoma	1.1e-05	4.88e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—sarcoma	1.09e-05	4.84e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—sarcoma	1.09e-05	4.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—sarcoma	1.08e-05	4.8e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—sarcoma	1.07e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—sarcoma	1.07e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—sarcoma	1.07e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—sarcoma	1.07e-05	4.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—sarcoma	1.07e-05	4.75e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—sarcoma	1.07e-05	4.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—sarcoma	1.06e-05	4.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—sarcoma	1.06e-05	4.72e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—sarcoma	1.06e-05	4.72e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	1.06e-05	4.71e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—sarcoma	1.05e-05	4.65e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—sarcoma	1.04e-05	4.65e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—sarcoma	1.04e-05	4.64e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—sarcoma	1.04e-05	4.64e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—sarcoma	1.04e-05	4.64e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—sarcoma	1.02e-05	4.52e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—sarcoma	1.01e-05	4.5e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—sarcoma	1e-05	4.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—sarcoma	9.95e-06	4.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—sarcoma	9.9e-06	4.41e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—sarcoma	9.88e-06	4.4e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—sarcoma	9.86e-06	4.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—sarcoma	9.72e-06	4.33e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—sarcoma	9.72e-06	4.33e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—sarcoma	9.67e-06	4.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—sarcoma	9.64e-06	4.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—sarcoma	9.63e-06	4.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—sarcoma	9.63e-06	4.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—sarcoma	9.58e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—sarcoma	9.58e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—sarcoma	9.53e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—sarcoma	9.51e-06	4.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—sarcoma	9.33e-06	4.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—sarcoma	9.33e-06	4.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—sarcoma	9.21e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—sarcoma	9.21e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—sarcoma	8.99e-06	4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—sarcoma	8.92e-06	3.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—sarcoma	8.87e-06	3.95e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—sarcoma	8.78e-06	3.91e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—sarcoma	8.76e-06	3.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—sarcoma	8.68e-06	3.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—sarcoma	8.58e-06	3.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—sarcoma	8.58e-06	3.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—sarcoma	8.53e-06	3.8e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—sarcoma	8.4e-06	3.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—sarcoma	8.4e-06	3.74e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—sarcoma	8.4e-06	3.74e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—sarcoma	8.38e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—sarcoma	8.2e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—sarcoma	7.99e-06	3.56e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—sarcoma	7.93e-06	3.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—sarcoma	7.93e-06	3.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—sarcoma	7.64e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—sarcoma	7.29e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—sarcoma	7.05e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—sarcoma	7.05e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—sarcoma	6.97e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—sarcoma	6.74e-06	3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—sarcoma	6.74e-06	3e-05	CbGpPWpGaD
